Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The impact of COVID-19 on rare metabolic patients and healthcare providers: results from two MetabERN surveys

1 Dec 2020

Abstract excerpt

The ongoing coronavirus disease 2019 (COVID-19) pandemic has caused disruption in all aspects of daily life, including the management and treatment of rare inherited metabolic disorders (IMDs). To perform a preliminary assessment of the incidence of COVID-19 in IMD patients and the impact of the coronavirus emergency on the rare metabolic community between March and April 2020, the European Reference Network for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to COVID-19 and healthcare impacts
Share to COVID-19 Clinical Research Studies
Share to Liver Disease Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33272301
DOI: 10.1186/s13023-020-01619-x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The impact of COVID-19 on rare metabolic patients and healthcare providers: results from two MetabERN surveysPMID 33272301Read ↗

Impact of COVID-19 Infection in Patients with Inherited Metabolic Diseases: A National Multicenter Study from the French IMDs Healthcare Network for Rare DiseasesSemantic proximity Read ↗

Impact of the SARS‐CoV ‐2 pandemic on the health of individuals with intoxication‐type metabolic diseases—Data from the E‐IMD consortiumSemantic proximity Read ↗

Impact of Covid19 Pandemic on Patients with Rare Diseases in Spain, with a Special Focus on Inherited Metabolic DiseasesSemantic proximity Read ↗

Impact of the COVID-19 Pandemic on the Care of Rare and Undiagnosed Diseases Patients in France: A Longitudinal Population-Based StudySemantic proximity Read ↗

Towards needed improvements in inherited metabolic medicine in adulthood: The SIMMESN adult metabolic working group and MetabERN Joint Position Statement.Semantic proximity Read ↗

Impact of the Covid-19 pandemic on the care of rare and undiagnosed diseases patients in France: a longitudinal population-based studySemantic proximity Read ↗

Time to diagnosis and determinants of diagnosis delays of people living with a rare disease: a Rare Barometer retrospective patient surveySemantic proximity Read ↗

Impact of the COVID-19 Pandemic on Management of Children and Adolescents with Type 1 DiabetesSemantic proximity Read ↗

Exploring the impact of the COVID-19 pandemic on patients with type 2 diabetes and primary care utilisation: a scoping reviewSemantic proximity Read ↗

Metabolic indicators associated with non-communicable diseases deteriorated in the Coronavirus Disease 2019 outbreak: evidence from a two-center, retrospective, self-controlled studySemantic proximity Read ↗

Pre-hospital Management of Patients with COVID-19 and the Impact on HospitalisationSemantic proximity Read ↗

Impact of COVID-19 on diagnoses, monitoring and mortality in people with type 2 diabetes: a UK-wide cohort study involving 14 million people in primary careSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.